Biomark Diagnostics Inc. (CSE:BUX)
Canada flag Canada · Delayed Price · Currency is CAD
0.3550
0.00 (0.00%)
Aug 15, 2025, 10:10 AM EDT

Biomark Diagnostics Ratios and Metrics

Millions CAD. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2016 - 2020
Period Ending
Aug '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2016 - 2020
Market Capitalization
332225151631
Upgrade
Market Cap Growth
-9.92%-9.92%60.95%-1.62%-48.77%128.35%
Upgrade
Enterprise Value
322426171731
Upgrade
Last Close Price
0.350.270.300.210.230.42
Upgrade
PS Ratio
215.89145.04152.12100.50356.91-
Upgrade
PB Ratio
19.1212.85-40.73-13.42-24.67-386.98
Upgrade
P/TBV Ratio
19.1212.85----
Upgrade
EV/Sales Ratio
198.65154.52161.35110.73393.16-
Upgrade
Debt / Equity Ratio
0.640.64-2.54-1.44-3.09-12.70
Upgrade
Asset Turnover
0.070.070.180.140.04-
Upgrade
Quick Ratio
2.142.140.160.060.310.98
Upgrade
Current Ratio
2.142.140.160.080.331.00
Upgrade
Return on Equity (ROE)
-340.70%-340.70%----
Upgrade
Return on Assets (ROA)
-60.59%-60.59%-117.29%-104.38%-66.20%-80.77%
Upgrade
Return on Capital (ROIC)
-67.44%-67.44%-148.56%-125.52%-71.12%-259.30%
Upgrade
Earnings Yield
-5.79%-8.62%-5.75%-11.94%-9.27%-3.57%
Upgrade
FCF Yield
-3.29%-4.90%-3.98%-5.96%-8.06%-2.64%
Upgrade
Buyback Yield / Dilution
-6.67%-6.67%-2.97%-6.22%-6.31%-2.82%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.